An international, Phase III clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare ...

At the 42nd Annual Chemotherapy Foundation Symposium, Erin Mulvey, MD, discussed the significant progress being made in the ...

Serum-free Media market Growth is Driven by Technological Advancements & Growing Demand for Cell-Based Therapies AUSTIN, TX, UNITED STATES, November 14, 2024 /EINPresswire / -- According to SNS ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

The FDA has given the green light to a clinical trial testing ATA-200, a gene therapy for limb-girdle muscular dystrophy ...

Ivermectin is an antiparasitic agent, and its potential as an anticancer agent has recently attracted increasing attention.

Kenai Therapeutics, a biotechnology company leveraging induced pluripotent stem cell (iPSC) technology to discover and develop a platform of off-the-shelf neuron replacement therapies for neurological ...

chemotherapy and radiation therapy, researchers said in background notes. The trial patients all had undergone chemotherapy, ...

Kebilidi is delivered into the putamen - a part of the brain that is involved with learning, motor control and speech - and ...

Blinded preliminary data demonstrate a positive trend and clear signal in Primary and Secondary endpoints –– Patient reported efficacy outcomes ...

In a sense, the combination begins to awaken the cells to their purpose within the body. You might say the treatment acts as a template of what is normal for the ... with the Beat and then sent to the ...

A scientist who was diagnosed with stage 3 cancer treated herself using lab-grown viruses, a method researchers say is 'not ...